Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans
Authors:
- Noa LapidotNLNoa Lapidot
- Michel AfarganMAMichel Afargan
- David KirmayerDKDavid Kirmayer
- Eytan MoorEMEytan Moor
- Yael MardorYMYael Mardor
- Michael FriedmanMFMichael Friedman
- Amnon HoffmanAHAmnon Hoffman
- 1 July 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Controlled Release
- Vol. 113 (3) , 208-215
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Formulation strategies for absorption windowsDrug Discovery Today, 2005
- Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage formsInternational Journal of Pharmaceutics, 2004
- Gastroretentive Delivery Systems: Hollow BeadsDrug Development and Industrial Pharmacy, 2004
- Expandable gastroretentive dosage formsJournal of Controlled Release, 2003
- Gastric Retentive Dosage Forms: A ReviewCritical Reviews™ in Therapeutic Drug Carrier Systems, 2003
- A New Approach in Gastroretentive Drug Delivery System Using CholestyramineDrug Delivery, 2003
- Floating Dosage Systems in Drug DeliveryCritical Reviews™ in Therapeutic Drug Carrier Systems, 2002
- Development of a Novel Controlled-Release System for Gastric RetentionPharmaceutical Research, 1997
- Controlled-Release Drug Delivery Systems for Prolonged Gastric Residence: An OverviewDrug Development and Industrial Pharmacy, 1996
- Controlled Gastric Emptying. III. Gastric Residence Time of a Nondisintegrating Geometric Shape in Human VolunteersPharmaceutical Research, 1993